Once approved, patients pay $50 for a one-month supply at the pharmacy, and refills do not require a new prior authorization as long as the patient remains on the same GLP-1 medication
Both formulations were mainly prescribed in patient at high (39.1% in oral and 31.6% in subcutaneous semaglutide group, respectively) or very high (45.2% in oral and 46.3% in subcutaneous semaglutide group, respectively) cardiovascular risk, without significant differences between the two groups (Supplementary Fig.S1v)
A health professional will interpret / advise on the results
Think of it as metabolic infrastructure maintenance, not performance enhancement
This reflects a pricing trend favouring competitive retail strategies, with stock levels generally stable but fluctuating during periods of high demand
New-onset constipation in patients over age 50 or accompanied by iron-deficiency anemia warrants evaluation to rule out colorectal pathology, per gastroenterology guidelines